Search Results - "Lara, Joshua"

Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B by Bencomo-Alvarez, Alfonso E., Rubio, Andres J., Olivas, Idaly M., Gonzalez, Mayra A., Ellwood, Rebecca, Fiol, Carme Ripoll, Eide, Christopher A., Lara, Joshua J., Barreto-Vargas, Christian, Jave-Suarez, Luis F., Nteliopoulos, Georgios, Reid, Alistair G., Milojkovic, Dragana, Druker, Brian J., Apperley, Jane, Khorashad, Jamshid S., Eiring, Anna M.

“…Tyrosine kinase inhibitors (TKIs) targeting BCR-ABL1 have revolutionized therapy for chronic myeloid leukemia (CML), paving the way for clinical development in…”
Get full text

Validation of three viable-cell counting methods: Manual, semi-automated, and automated by Cadena-Herrera, Daniela, Esparza-De Lara, Joshua E., Ramírez-Ibañez, Nancy D., López-Morales, Carlos A., Pérez, Néstor O., Flores-Ortiz, Luis F., Medina-Rivero, Emilio

“…[Display omitted] A viable cell count is essential to evaluate the kinetics of cell growth. Since the hemocytometer was first used for counting blood cells,…”
Get full text

Ethnic and border differences on blood cancer presentation and outcomes: A Texas population‐based study by Bencomo‐Alvarez, Alfonso E., Gonzalez, Mayra A., Rubio, Andres J., Olivas, Idaly M., Lara, Joshua J., Padilla, Osvaldo, Orazi, Attilio, Corral, Javier, Philipovskiy, Alexander, Gaur, Sumit, Mulla, Zuber D., Dwivedi, Alok K., Eiring, Anna M.

“…Background The Texas/Chihuahua (US/Mexico) border is a medically underserved region with many reported barriers for health care access. Although Hispanic…”
Get full text

19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML) by Lara, Joshua J, Bencomo-Alvarez, Alfonso E, Gonzalez, Mayra A, Olivas, Idaly M, Young, James E, Lopez, Jose L, Velazquez, Vanessa V, Glovier, Steven, Keivan, Mehrshad, Rubio, Andres J, Dang, Sara K, Solecki, Jonathan P, Allen, Jesse C, Tapia, Desiree N, Tychhon, Boranai, Astudillo, Gonzalo E, Jordan, Connor, Chandrashekar, Darshan S, Eiring, Anna M

“…26S proteasome non-ATPase subunits 1 (PSMD1) and 3 (PSMD3) were recently identified as prognostic biomarkers and potential therapeutic targets in chronic…”
Get full text

A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease by Serna, Carylinda, Lara, Joshua A, Rodrigues, Silas P, Marques, Alexandre F, Almeida, Igor C, Maldonado, Rosa A

“…Highlights • We report a peptide-based vaccine candidate for Chagas disease. • Use of immunoinformatics for selection of an immunogenic peptide. • Peptide…”
Get full text

26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy by Rubio, Andres J., Bencomo-Alvarez, Alfonso E., Young, James E., Velazquez, Vanessa V., Lara, Joshua J., Gonzalez, Mayra A., Eiring, Anna M.

“…Ever since the ubiquitin proteasome system was characterized, efforts have been made to manipulate its function to abrogate the progression of cancer. As a…”
Get full text

Clinical predictors of survival in young patients with small cell lung cancer: Results from the California Cancer Registry by Lara, Joshua D., Brunson, Ann, Riess, Jonathan W., Kelly, Karen, Lara, Primo N., Gandara, David R.

“…•One of the largest registry studies of younger patients with SCLC ever reported.•Serves as a more contemporary foundational reference for future research in…”
Get full text

Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism by Gonzalez, Mayra A., Olivas, Idaly M., Bencomo‐Alvarez, Alfonso E., Rubio, Andres J., Barreto‐Vargas, Christian, Lopez, Jose L., Dang, Sara K., Solecki, Jonathan P., McCall, Emily, Astudillo, Gonzalo, Velazquez, Vanessa V., Schenkel, Katherine, Reffell, Kelaiah, Perkins, Mariah, Nguyen, Nhu, Apaflo, Jehu N., Alvidrez, Efren, Young, James E., Lara, Joshua J., Yan, Dongqing, Senina, Anna, Ahmann, Jonathan, Varley, Katherine E., Mason, Clinton C., Eide, Christopher A., Druker, Brian J., Nurunnabi, Md, Padilla, Osvaldo, Bajpeyi, Sudip, Eiring, Anna M.

“…Tyrosine kinase inhibitors (TKIs) targeting BCR::ABL1 have turned chronic myeloid leukaemia (CML) from a fatal disease into a manageable condition for most…”
Get full text

19S Proteasome Subunits As Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML) by Lara, Joshua J., Bencomo, Alfonso E., Gonzalez, Mayra A., Olivas, Idaly M., Lopez, Jose L., Young, James E., Velazquez, Vanessa V., Glovier, Steven, Rubio, Andres J., Dang, Sara K., Solecki, Jonathan, Allen, Jesse, Tapia, Desiree N., Tychhon, Boranai, Astudillo, Gonzalo E., Chandrashekar, Darshan S., Eiring, Anna M.

Get full text

Determinants of Survival for Adolescents and Young Adults with Urothelial Bladder Cancer: Results from the California Cancer Registry by Lara, Joshua, Brunson, Ann, Keegan, Theresa H.M, Malogolowkin, Marcio, Pan, Chong-Xian, Yap, Stanley, White, Ralph deVere

“…Purpose Bladder cancer is a common malignancy often diagnosed in older adults. Previous studies have reported racial/ethnic disparities in bladder cancer…”
Get full text

Abstract 647: NF-kB associates with tyrosine kinase inhibitor resistance in chronic myeloid leukemia by Rubio, Andres J., Olivas, Idaly M., Bencomo, Alfonso E., Gonzalez, Mayra A., Lara, Joshua J., Ellwood, Rebecca, Ripoll-Fiol, Carme, Nteliopoulos, Georgios, Reid, Alistair, Milojkovic, Dragana, Apperley, Jane, Sorouri-Khorashad, Jamshid, Eiring, Anna M.

“…Tyrosine kinase inhibitors (TKIs) targeting BCR-ABL1 are effective at eliminating most BCR-ABL1+ cells in chronic myeloid leukemia (CML), but do not target CML…”
Get full text

Abstract 4343: Retrospective study of incidence and survival for patients with hematological malignancies residing at the U.S./Mexico border by Bencomo, Alfonso E., Rubio, Andres J., Gonzalez, Mayra A., Olivas, Idaly M., Lara, Joshua J., Ghimire, Kiran, Padilla, Osvaldo, Padilla, Angelica, Hakim, Nawar, Orazi, Attilio, Corral, Javier, Philipovskiy, Alexander, Gaur, Sumit, Eiring, Anna M.

“…Introduction: Hispanics represent the largest minority group in the United States (U.S.), with 57.5 million individuals. The majority of Hispanics in the U.S…”
Get full text

Abstract 648: Role of G0S2 in chronic myeloid leukemia and TKI resistance by Gonzalez, Mayra A., Bencomo, Alfonso E., Barreto-Vargas, Christian, Rubio, Andres J., Olivas, Idaly M., Lara, Joshua J., Senina, Anna, Ahmann, Jonathan, Varley, Katherine T., Jave-Suarez, Luis F., Thomas, O'Hare, Deininger, Michael W., Eiring, Anna M.

“…Tyrosine kinase inhibitors (TKIs) targeting BCR-ABL1 have turned chronic myeloid leukemia (CML) from a fatal to a chronic disease. However, resistance is a…”
Get full text

Proteasome 26S subunit, non-ATPases 1 , play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B by Bencomo-Alvarez, Alfonso E, Rubio, Andres J, Olivas, Idaly M, Gonzalez, Mayra A, Ellwood, Rebecca, Fiol, Carme Ripoll, Eide, Christopher A, Lara, Joshua J, Barreto-Vargas, Christian, Jave-Suarez, Luis F, Nteliopoulos, Georgios, Reid, Alistair G, Milojkovic, Dragana, Druker, Brian J, Apperley, Jane, Khorashad, Jamshid S, Eiring, Anna M

“…Tyrosine kinase inhibitors (TKIs) targeting BCR-ABL1 have revolutionized therapy for chronic myeloid leukemia (CML), paving the way for clinical development in…”
Get full text

NF-κB-Dependent Activation of the Proteasome Components, PSMD1 and PSMD3, As a Mechanism of Resistance to Imatinib by Olivas, Idaly Maria, Lara, Joshua, Ellwood, Rebecca, Ripoll Fiol, Carme, Rubio, Andres J, Bencomo, Alfonso Enrique, Gonzalez, Mayra Alejandra, Nteliopoulos, Georgios, Reid, Alistair, Milojkovic, Dragana, Apperley, Jane, Sorouri Khorashad, Jamshid, Eiring, Anna M.

“…Tyrosine kinase inhibitors (TKIs) targeting BCR-ABL1 are remarkably effective therapies in chronic myeloid leukemia (CML). Despite clinical success, TKIs do…”
Get full text

Retrospective Study of Incidence and Survival for Patients with Hematologic Malignancies Residing at the U.S./Mexico Border by Bencomo, Alfonso Enrique, Rubio, Andres J, Gonzalez, Mayra Alejandra, Olivas, Idaly Maria, Lara, Joshua, Ghimire, Kiran, Padilla, Osvaldo, Padilla, Angelica, Hakim, Nawar, Orazi, Attilio, Corral, Javier, Philipovskiy, Alexander, Gaur, Sumit, Eiring, Anna M.

“…Introduction: Hispanics represent the largest minority group in the United States (U.S.), with 57.5 million individuals (18% of the population). Most U.S…”
Get full text

Determinants of survival in adolescents and young adults with urothelial cancer: Results from the California Cancer Registry by Lara, Joshua David, Brunson, Ann, de Vere White, Ralph, Pan, Chong-xian, Yap, Stanley A, Balagtas, Jay R.

“…Abstract only…”
Get full text

A synthetic peptide fromTrypanosoma cruzimucin-like associated surface protein as candidate for a vaccine against Chagas disease by Serna, Carylinda, Lara, Joshua A, Rodrigues, Silas P, Marques, Alexandre F, Almeida, Igor C, Maldonado, Rosa A

“…Chagas disease, caused byTrypanosoma cruzi, is responsible for producing significant morbidity and mortality throughout Latin America. The disease has recently…”
Get full text

Phylogeography of the natal puddle frog Phrynobatrachus natalensis (Anura: Phrynobatrachidae) in Sub-Saharan Africa by Lara, Joshua Adan

“…The Family Phrynobatrachidae (Laurent, 1941) has one genus (Phrynobatrachus, Günther, 1862) containing 89 species. Commonly known as puddle frogs, they…”
Get full text